Current Press Releases

April 20, 2010 - Phenomix Announces Positive Results from a Phase 3 Study of Dutogliptin in Type 2 Diabetes Mellitus

December 2, 2009 - Phenomix Grants Chiesi Farmaceutici European Rights to Dutogliptin for Diabetes

October 28, 2008 - Phenomix Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor PHX1766

October 23, 2008 - Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes

May 16, 2008 - Phenomix Announces PHX1149 Phase 2B Clinical Trial Results For Type 2 Diabetes

January 25, 2008 - Phenomix Files Registration Statement For Proposed Initial Public Offering